| 摘要 |
The medicament is for application to the skin. This medicament contains, in combination, in a pharmaceutical vehicle acceptable for administration to the skin, at least one corticosteroid in a proportion of between 0.0005 and 0.5% by weight and at least one beta -agonist. This medicament is intended, more especially, for the treatment of dermatitis and dermatosis, psoriasis, epidermolytic hyperkeratosis, lamellar ichthyosis, pemphigus or gout. |
